Showing 121-130 of 9380 results for "".
- Tulisokibart Meets Phase 2b Primary Endpoint in Hidradenitis Suppurativahttps://practicaldermatology.com/news/tulisokibart-meets-phase-2b-primary-endpoint-in-hidradenitis-suppurativa/2488592/Tulisokibart, an investigational monoclonal antibody targeting tumor necrosis factor-like cytokine 1A (TL1A), met the primary endpoint in a Phase 2b trial evaluating the therapy in patients with moderate-to-severe hidradenitis suppurativa (HS), according to results presente
- Science of Skin Summit: AI in Medicine Requires More Than Knowing Which Model Scores Besthttps://practicaldermatology.com/news/science-of-skin-summit-ai-in-medicine-requires-more-than-knowing-which-model-scores-best/2488531/Artificial intelligence models are evolving so rapidly that clinicians may struggle to determine which tools they can trust, but choosing the model that performs best on a standardized test may not provide the answer. Speaking at the Science of Skin Summit, Roxana Daneshjou, MD, PhD, discu
- Science of Skin Urticaria Discussion Highlights Expanding Treatment Options and Need to Measure Disease Controlhttps://practicaldermatology.com/news/science-of-skin-urticaria-discussion-highlights-expanding-treatment-options-and-need-to-measure-disease-control/2488529/The growing treatment armamentarium for chronic spontaneous urticaria (CSU) is giving dermatologists more opportunities to individualize therapy, but effective management begins with fundamentals: selecting and adequately dosing antihistamines, identifyi
- Report: Estimated 4.7 Million Americans Diagnosed With NMSC Annuallyhttps://practicaldermatology.com/news/report-estimated-47-million-americans-diagnosed-with-nmsc-annually/2488474/A new analysis from SkinCure Oncology estimates that 4.7 million Americans are diagnosed with nonmelanoma skin cancer (NMSC) each, approximately 42% higher than a commonly cited estimate based on 2012 data.
- Meta-Analysis: IBD Events Are Rare With IL-17 Inhibitors in HShttps://practicaldermatology.com/news/meta-analysis-finds-rare-ibd-events-with-il-17-inhibitors-in-hs/2488443/Interleukin (IL)-17 inhibitors were not associated with a statistically significant increase in inflammatory bowel disease (IBD) risk among patients with hidradenitis suppurativa (HS) in a systematic review and meta-analysis published online in JAMA Dermatology. IBD Events Remain
- Ultra-Processed Foods May Influence Pediatric Acne Through mTORC1 Signaling: Studyhttps://practicaldermatology.com/news/ultra-processed-foods-may-influence-pediatric-acne-through-mtorc1-signaling-study/2488415/Ultra-processed foods may contribute to pediatric acne through metabolic, inflammatory, and microbiome-related pathways, according to a comprehensive review published in the International Journal of Molecular Sciences. Researchers examined current evidence connecting ultra-processed foods
- Omalizumab Shows Median 3.1-Year Drug Survival in Chronic Urticariahttps://practicaldermatology.com/news/omalizumab-shows-median-31-year-drug-survival-in-chronic-urticaria/2488414/Omalizumab demonstrated a median drug survival of more than 3 years among patients with chronic urticaria (CU), with successful disease control rather than adverse events emerging as a common reason for treatment discontinuation, according to a systematic review an
- AI Analysis Maps Environmental and Immune Signatures in Pediatric ADhttps://practicaldermatology.com/news/ai-analysis-maps-environmental-and-immune-signatures-in-pediatric-atopic-dermatitis/2488367/A machine learning (ML)-based analysis of environmental, immune, and transcriptomic data identified distinct protective and susceptibility clusters associated with pediatric atopic dermatitis (AD) among AmaXhosa children in South Africa. Published in PLoS Medicine, the observation
- NEA Expands Seal of Acceptance Program to Makeup Productshttps://practicaldermatology.com/news/nea-expands-seal-of-acceptance-program-to-makeup-products/2488269/The National Eczema Association (NEA) has expanded its Seal of Acceptance program to include color cosmetics, opening the program to makeup products for the first time since the Seal was established in 2008. The initial expan
- PCA SKIN Launches Microbiome-Focused Acne Control Cleanserhttps://practicaldermatology.com/news/pca-skin-launches-microbiome-focused-acne-control-cleanser/2488268/PCA SKIN has launched Acne Control Prebiotic Gel Cleanser, a new daily cleanser formulated to address acne while supporting the skin barrier and microbiome, according to information provided by the company. The cleanser, laun